print Print
Please select which sections you would like to print:
verifiedCite
While every effort has been made to follow citation style rules, there may be some discrepancies. Please refer to the appropriate style manual or other sources if you have any questions.
Select Citation Style
Feedback
Corrections? Updates? Omissions? Let us know if you have suggestions to improve this article (requires login).
Thank you for your feedback

Our editors will review what you’ve submitted and determine whether to revise the article.

News

After a genetic test, Georgie is taking steps to reduce her cancer risk Oct. 25, 2024, 11:59 PM ET (ABC News (Australia))

Techniques such as FISH, CGH, and PCR have high rates of sensitivity and specificity. These procedures provide results more quickly than traditional karyotyping because no cell culture is required. FISH can detect genetic deletions involving one to five genes. It is also useful in detecting moderate-sized deletions, such as those causing Prader-Willi syndrome. CGH is more sensitive than FISH and is capable of detecting a variety of small chromosomal rearrangements, deletions, and duplications. The analysis of individual genes also has been greatly enhanced by the development of PCR and recombinant DNA technology. In recombinant DNA technology, small DNA fragments are isolated and copied, thereby producing unlimited amounts of cloned material. Once cloned, the various genes and gene products can be used to study gene function both in healthy individuals and those with disease. Recombinant DNA and PCR methods can detect any change in DNA, down to a one-base-pair change, such as a point mutation or a single nucleotide polymorphism, out of the three billion base pairs in the human genome. The detection of these changes is facilitated by DNA probes that are labeled with radioactive isotopes or fluorescent dyes. Such methods can be used to identify persons who are carriers for inherited conditions, such as hemophilia A, polycystic kidney disease, sickle cell anemia, Huntington disease, cystic fibrosis, and hemochromatosis.

Biochemical tests

Biochemical tests primarily detect enzymatic defects such as phenylketonuria, porphyria, and glycogen-storage disease. Although testing of newborns for all these abnormalities is possible, it is not cost-effective, because some of these conditions are quite rare. Screening requirements for these disorders vary and depend on whether the disease is sufficiently common, has severe consequences, and can be treated or prevented if diagnosed early and whether the test can be applied to the entire population at risk.

Genetic testing and genealogy

Once the domain of oral traditions and written pedigrees, genealogy in the modern era has become grounded in the science of genetics. Increased rigour in the field has been made possible by the development and ongoing refinement of methods to accurately trace genes and genetic variations through generations. Genetic tests used in genealogy are mainly intended to identify similarities and differences in DNA between living humans and their ancestors. In some instances, however, in the process of tracing genetic lineages, gene variations associated with disease may be detected.

Methods used in genealogical genetics analysis include Y chromosome testing, mitochondrial DNA (mtDNA) testing, and detection of ancestry-associated genetic variants that occur as single nucleotide polymorphisms (SNPs) in the human genome. Y chromosome testing is based on genetic comparison of Y chromosomes, from males. Because males with a common male ancestor have matching Y chromosomes, scientists are able to trace paternal lineages and thereby determine distant relationships between males. Such analyses allow genealogists to confirm whether males with the same surname are related. Likewise, maternal lineages can be traced genetically through mtDNA testing, since the mitochondrial genome is inherited only from the mother. Maternal lineage tests typically involve analysis of a segment in mtDNA known as hypervariable region 1; comparison of this segment against reference mtDNA sequences (e.g., Cambridge Reference Sequence) enables scientists to reconstruct an individual’s maternal genetic lineage.

Following the completion of the Human Genome Project in 2003, it became possible to more efficiently scan the human genome for SNPs and to compare SNPs occurring in the genomes of human populations in different geographical regions of the world. The analysis of this information for genetic testing and genealogical purposes forms the basis of biogeographical ancestry testing. These tests typically make use of panels of ancestry informative markers (AIMs), which are SNPs specific to human populations and their geographical areas that can be used to infer ancestry. In 2010 a study using genome-wide SNP analysis incorporating ancestral information successfully traced persons in Europe to the villages in which their grandparents lived. The technique was expected to advance genetic testing intended to map an individual’s geographical ancestry.

This article was most recently revised and updated by Kara Rogers.